Inspire Medical Systems, which sells its proprietary Inspire therapy for sleep apnea, filed on Friday with the SEC to raise up to $86 million in an initial public offering.
The Maple Grove, MN-based company was founded in 2007 and booked $29 million in sales for the 12 months ended December 31, 2017. It plans to list on the NYSE under the symbol INSP. Inspire Medical Systems filed confidentially on February 14, 2018. BofA Merrill Lynch and Goldman Sachs are the joint bookrunners on the deal. No pricing terms were disclosed.
